Home » Fake Avastin Took Murky Path to U.S.
Fake Avastin Took Murky Path to U.S.
A second case of a counterfeit cancer drug reaching the U.S. market is focusing attention on the obscure overseas suppliers — sometimes operating in weakly regulated markets like Turkey — that are involved in shipping the medicines to U.S. doctors.
The Wall Street Journal
The Wall Street Journal
Upcoming Events
-
23Apr
-
25Apr
-
07May
-
14May
-
30May